Nitric oxide-generating β-adrenergic blocker nipradilol preserves postischemic cardiac function

Annals of Thoracic Surgery

Volumn 68, Issue 3, 1999, Pages 844-849

  Horimoto, Hitoshi ^a   Saltman, Adam E ^a   Gaudette, Glenn R ^a   Krukenkamp, Irvin B ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; N(G) NITROARGININE METHYL ESTER; NIPRADILOL; NITRIC OXIDE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BETA ADRENERGIC RECEPTOR BLOCKING; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART VENTRICLE PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARGININE; CORONARY CIRCULATION; ENZYME INHIBITORS; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPANOLAMINES; RABBITS; VENTRICULAR PRESSURE;

EID: 0032744921     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00809-7     Document Type: Conference Paper

References (19)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
2. Downey J.M. Ischemic preconditioning nature's own cardioprotective intervention . Trends Cardiovasc Med. 2:1992;170-176.
3. Parratt J.R., Kane K.A. K-ATP channels in ischemic preconditioning. Cardiovasc Res. 28:1994;783-787.
4. Yao Z., Gross J.G. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res. 73:1993;1193-1201.
5. Hu K., Nattel S. Mechanism of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 92:1995;2259-2265.
6. Khandoudi N., Moffat M.P., Karmazyn M. Adenosine-sensitive alpha 1-adrenoceptor effects on reperfused ischemic hearts comparison with phorbol ester . Br J Pharmacol. 112:1994;1007-1016.
7. Banerjee A., Locke-Winter C., Rogers K.B., et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res. 73:1993;656-670.
8. Yokota R., Fujiwara H., Miyamae M., et al. Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts. Am J Physiol. 268:1995;H1149-H1157.
9. Vegh A., Szekeres L., Parratt J. Preconditioning of the ischemic myocardium involvement of the L-arginine-nitric oxide pathway . Br J Pharmacol. 107:1992;648-652.
10. Horimoto H., Gaudette G.R., Krukenkamp I.B. The nitric oxide is a requisite cofactor to generate ATP-sensitive potassium channel-mediated preconditioning. Surg Forum. 48:1998;202-203.
11. Amezcua J.L., Palmer R.M.J., Sonza B.M., Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol. 97:1989;1119-1124.
12. Patterson E., Jackman W.N., Scherlag B.J., Lazzara R. The monophasic action potential in clinical cardiology. [Review] Clin Cardiol. 14:1991;505-510.
13. Harris L., Kimura Y., Shaikh N. Phospholipase inhibition and electrophysiology of acute ischemia studies with amrinone . J Mol Cell Cardiol. 25:1993;1075-1090.
14. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., Michael T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA. 90:1993;347-351.
15. Levi R.C., Alloatti G., Fischmeister R. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Eur J Physiol. 413:1989;685-687.
16. Xie Y.W., Shen W., Zhao G., Xu X., Wolin M.S., Hintze T.H. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vivo. Implication for the development of heart failure. Circ Res. 79:1996;381-387.
17. Moncada S., Higgd A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
18. Maulik N., Engelman D.T., Watanabe M., et al. Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation. 94:(Suppl 2):1996;II-398-II-406.
19. Galaris D., Cadenas E., Hochstein P. Redox cycling of myoglobin and ascorbate a potential protective mechanism against oxidative reperfusion injury in muscle . Arch Biochem Biophys. 273:1989;497-504.